Literature DB >> 26256486

Cannabis (Marijuana) - Effects on Human Performance and Behavior.

M A Huestis1.   

Abstract

Cannabis is one of the oldest and most commonly abused drugs in the world. Recently, tremendous advances have been made in our understanding of the endogenous cannabinoid system with the identification of cannabinoid receptors, cannabinoid receptor antagonists, endogenous neurotransmitters, metabolic enzymes, and reuptake mechanisms. These advances have helped us to elucidate the mechanisms of action of cannabis and the side effects and toxicities associated with its use. In addition, potential therapeutic applications are being investigated for the use of smoked cannabis and synthetic THC (dronabinol). Most workplace, military, and criminal justice positive urine drug tests are due to the use of cannabis. In addition, alternative matrices, including saliva, sweat, and hair, are being utilized for monitoring cannabis use in treatment, employment, and criminal justice settings. Experimental laboratory studies have identified cognitive, physiological, and psychomotor effects following cannabis. Epidemiological studies reveal that cannabis is the most common illicit drug world-wide in impaired drivers, and in motor vehicle injuries and fatalities. Driving simulator studies also indicate performance impairment following cannabis use; however, the results of open- and closed-road driving studies and of culpability studies do not consistently document increased driving risk. Clearly a combination of ethanol and cannabis use significantly increases risks. This article reviews the pharmacokinetics and pharmacodynamics of cannabis and places special emphasis on the effects of cannabis on complex tasks such as driving and flying.
Copyright © 2002 Central Police University.

Entities:  

Keywords:  cannabinoids; cannabis; driving; hair; impairment; marijuana; oral fluid; performance; plasma; sweat; tetrahydrocannabinol; urine; whole blood

Year:  2002        PMID: 26256486

Source DB:  PubMed          Journal:  Forensic Sci Rev        ISSN: 1042-7201


  13 in total

1.  The prevalence of cannabis-involved driving in California.

Authors:  Mark B Johnson; Tara Kelley-Baker; Robert B Voas; John H Lacey
Journal:  Drug Alcohol Depend       Date:  2011-11-17       Impact factor: 4.492

2.  Urinary concentrations of PAH and VOC metabolites in marijuana users.

Authors:  Binnian Wei; K Udeni Alwis; Zheng Li; Lanqing Wang; Liza Valentin-Blasini; Connie S Sosnoff; Yang Xia; Kevin P Conway; Benjamin C Blount
Journal:  Environ Int       Date:  2015-12-12       Impact factor: 9.621

3.  Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Justin L Poklis; Candace C Thompson; Kelly A Long; Aron H Lichtman; Alphonse Poklis
Journal:  J Anal Toxicol       Date:  2010-10       Impact factor: 3.367

4.  Postmortem redistribution of THC in the pig.

Authors:  Bertrand Brunet; Thierry Hauet; William Hébrard; Yves Papet; Gérard Mauco; Patrick Mura
Journal:  Int J Legal Med       Date:  2010-01-07       Impact factor: 2.686

Review 5.  Current knowledge on cannabinoids in oral fluid.

Authors:  Dayong Lee; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2013-08-25       Impact factor: 3.345

Review 6.  Medical marijuana and driving: a review.

Authors:  Mark J Neavyn; Eike Blohm; Kavita M Babu; Steven B Bird
Journal:  J Med Toxicol       Date:  2014-09

7.  Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs.

Authors:  Nadine Schaefer; Mattias Kettner; Matthias W Laschke; Julia Schlote; Andreas H Ewald; Michael D Menger; Hans H Maurer; Peter H Schmidt
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

8.  Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1.

Authors:  Patrizia Ratano; Maura Palmery; Viviana Trezza; Patrizia Campolongo
Journal:  Front Pharmacol       Date:  2017-04-12       Impact factor: 5.810

Review 9.  Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects.

Authors:  Jules A A C Heuberger; Adam F Cohen
Journal:  Sports Med       Date:  2019-04       Impact factor: 11.136

10.  Assessment of the Abuse Liability of Synthetic Cannabinoid Agonists JWH-030, JWH-175, and JWH-176.

Authors:  Reinholdgher Tampus; Seong Shoon Yoon; June Bryan de la Peña; Chrislean Jun Botanas; Hee Jin Kim; Joung-Wook Seo; Eun Ju Jeong; Choon Gon Jang; Jae Hoon Cheong
Journal:  Biomol Ther (Seoul)       Date:  2015-11-01       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.